Boston Medical Center

Advances in Big Data for Precision Medicine, Novel Technologies to Determine a Pathogen's Susceptibility to Antibiotics, the Microbiome's Impact on Childhood Undernutrition, and More Draw Nearly 20,000 Attendees to 2023 AACC Annual Scientific Meeting

Retrieved on: 
Thursday, July 27, 2023
Infection, Emory University School of Medicine, Disruptive innovation, Medical laboratory, University, Therapy, AACC, Diagnosis, Big data, Gastrointestinal tract, University of California, San Francisco, Boston Medical Center, Health equity, Single-cell analysis, Woman, Cell, Mass spectrometry, Collection, Patient, Medicine, Hematology, Sickle cell disease, Artificial intelligence, Knowledge, Health, Automation, Disease, Medical device, Pharmaceutical industry

The meeting's 250-plus sessions affirmed that laboratory medicine professionals are essential to patient care.

Key Points: 
  • The meeting's 250-plus sessions affirmed that laboratory medicine professionals are essential to patient care.
  • More attendees are expected today, the last day of the meeting.
  • In addition, this year's Clinical Lab Expo boasted 910 exhibitors, a testament to the health and vibrancy of the field.
  • As part of ADLM's Disruptive Technology Award competition, biotech innovators presented novel technologies that could help more patients get accurate diagnoses.

United Digestive Physician Elected ACG Governor of Georgia

Retrieved on: 
Thursday, July 27, 2023
Indiana University, University, International, Gastroenterology, UD, The American Journal of Gastroenterology, Indiana University School of Medicine, Editorial Board at The Wall Street Journal, Public policy, Liver transplantation, Syphon Filter, American Journal, Patient, Physician, Medical Center, Associate, Member, American College of Gastroenterology, American College, UCLA, Health, MPH, ACG, Boston Medical Center, United Nations Credentials Committee, Nursing, MD

ATLANTA, July 27, 2023 /PRNewswire/ -- Hetal A. Karsan, MD, an Atlanta Gastroenterology Associates physician, has been elected as the newest Governor of Georgia for the American College of Gastroenterology (ACG). Dr. Karsan will serve a term of three years.

Key Points: 
  • ATLANTA, July 27, 2023 /PRNewswire/ -- Hetal A. Karsan, MD, an Atlanta Gastroenterology Associates physician, has been elected as the newest Governor of Georgia for the American College of Gastroenterology (ACG).
  • He is currently the Chair of the Credentials Committee for Memberships and the International Governor for the American College of Gastroenterology.
  • As the newly elected Governor of Georgia, Dr. Karsan plans to advance the ACG's public policy agenda directly to federal policymakers and help remove barriers that directly affect patient care.
  • "I am honored to have been elected as ACG's Governor of Georgia.

Microbiome-Directed Therapies for Undernutrition, Big Data for Precision Medicine, Health Equity, and More to Be Explored at 2023 AACC Annual Scientific Meeting & Clinical Lab Expo

Retrieved on: 
Monday, July 24, 2023
Emory University School of Medicine, University, Cardiovascular disease, Therapy, AACC, Health, Sickle cell disease, University of California, San Francisco, Boston Medical Center, Personalized medicine, Human Genome Sciences, Health equity, Medicine, Cell, Equity, Translation, Collection, Patient, Washington University School of Medicine, Hematology, Knowledge, Racism, Cardiology, Death, Health information management, Biology, Pharmaceutical industry, Health care, Woman

ANAHEIM, Calif., July 23, 2023 /PRNewswire/ -- At the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory experts will present cutting-edge research and technology that is shaping the future of clinical testing and patient care.

Key Points: 
  • ANAHEIM, Calif., July 23, 2023 /PRNewswire/ -- At the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory experts will present cutting-edge research and technology that is shaping the future of clinical testing and patient care.
  • In the meeting's opening plenary, Dr. Jeffrey I. Gordon discusses the possibility of developing microbiome-directed therapies to address this devastating global health problem.
  • Additionally, at the Clinical Lab Expo, more than 900 exhibitors will display innovative technologies that are just coming to market in every clinical lab discipline.
  • "The 2023 AACC Annual Scientific Meeting program showcases the versatility of laboratory medicine professionals and the enormous impact they have on improving health and healthcare," said AACC CEO Mark J.

The Inner Circle Acknowledges, Szymon Sami Rosenblatt as a Top Pinnacle Platinum Healthcare Professional for his contributions to the field of Neurology

Retrieved on: 
Monday, July 17, 2023
Deep brain stimulation, Central nervous system, University, Education, Tetraplegia, Neurosurgery, Stroke, Neoplasm, DSM-IV codes, Spinal cord, Infection, The House Institute Foundation, Spine, Castle Connolly Medical, Head, Chronic pain, Rehabilitation, Brain, Multimedia, Boston University Medical Campus, Sympathetic nervous system, Disorder, Inner circle, Science, Harvard Medical School, Congress, American Board of Commissioners for Foreign Missions, Ephraim McDowell Regional Medical Center, American Association of Neurological Surgeons, Medical director, Congress of Neurological Surgeons, Diagnosis, Ascension, Boston Medical Center, Northwestern University, Memory, Dentistry, MD, Neurology

HIGHLAND PARK, Ill., July 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Szymon Sami Rosenblatt is acknowledged as a Top Pinnacle Platinum Healthcare Professional for his contributions to the field of Neurology.

Key Points: 
  • HIGHLAND PARK, Ill., July 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Szymon Sami Rosenblatt is acknowledged as a Top Pinnacle Platinum Healthcare Professional for his contributions to the field of Neurology.
  • Dr. Rosenblatt pursued higher education at the University of Düsseldorf in Germany where he earned an MD and completed a fellowship in general physiology at Harvard Medical School.
  • An expert in neurosurgery, Dr. Rosenblatt focuses on surgical treatment for brain- and spina tumors; pituitary surgery; surgery for facial pain; degenerative spine disorders; and deep brain stimulation for movement disorders.
  • Dr. Rosenblatt noted that neurosurgeons diagnose and treat disorders of the central nervous system, often by performing surgery on the brain or spine.

BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer

Retrieved on: 
Wednesday, July 12, 2023
GSK, Brainstorm, Therapy, Internal medicine, Advisory Committee, Research, Medicine, Science, American Board of Commissioners for Foreign Missions, MD, Psychiatry, PDUFA, Neurology, Rare, FDA, Boston Medical Center, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, University of Bordeaux, ALS, Food, Pharmaceutical industry

NEW YORK, July 12, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the appointment of Bob Dagher, MD, as Executive Vice President and Chief Development Officer effective July 17, 2023. Dr. Dagher will serve on BrainStorm's executive leadership team reporting to Stacy Lindborg, Ph.D., co-CEO of BrainStorm.  He will be responsible for the portfolio strategy and advancement of clinical development plans towards regulatory approval, including the expansion of NurOwn into new diseases and the translation of pre-clinical research into first-in-human trials. 

Key Points: 
  • NEW YORK, July 12, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the appointment of Bob Dagher, MD, as Executive Vice President and Chief Development Officer effective July 17, 2023.
  • Dr. Dagher will serve on BrainStorm's executive leadership team reporting to Stacy Lindborg, Ph.D., co-CEO of BrainStorm.
  • Dr. Dagher joins BrainStorm from Enveric Biosciences where, as Chief Medical Officer, he was responsible for defining the portfolio strategy and advancement of development plans toward regulatory approvals.
  • I believe Brainstorm has an innovative and versatile, industry-leading stem cell technology platform, which can rapidly advance autologous targeted therapeutics from bench to clinical development and eventual commercialization.

Health in Her HUE to Host Discussion Around Fibroids Awareness and Launch the Fibroids-focused Care Squad Program during Fibroid Awareness Month

Retrieved on: 
Monday, June 26, 2023
Survivor, Endometriosis, Partnership, Boston University Chobanian & Avedisian School of Medicine, Obstetrics, Education, Boston Medical Center, Health equity, Woman, Human, Black, SMPA, Boston University School of Public Health, Patient, SAN, Roivant Sciences, Uterine fibroid, Disease, Gynaecology, Mortality, BRCA, Fibroid, MPH, Breast cancer, Therapy, Empowerment, Nursing, Health

NEW YORK and SAN MATEO, Calif., June 26, 2023 /PRNewswire/ -- Today, Health in Her HUE ("HIHH"), a company dedicated to connecting Black women and women of color to culturally competent and sensitive healthcare providers, announced an ongoing collaboration with Myovant Sciences Ltd. ("Myovant"), soon to be Sumitomo Pharma America, Inc. ("SMPA") as a result of the combination announced April 2023. The collaboration will kick-off with a fireside chat titled "Fighting Fibroids Together: A Candid Conversation Over Brunch," in New Orleans, Louisiana on July 1st, 2023 during the ESSENCE festival weekend. In acknowledgement of Fibroid Awareness Month, this event aims to support education and awareness efforts for historically underserved populations diagnosed with uterine fibroids.

Key Points: 
  • The collaboration will kick-off with a fireside chat titled "Fighting Fibroids Together: A Candid Conversation Over Brunch," in New Orleans, Louisiana on July 1st, 2023 during the ESSENCE festival weekend.
  • In acknowledgement of Fibroid Awareness Month, this event aims to support education and awareness efforts for historically underserved populations diagnosed with uterine fibroids.
  • The event will help launch HIHH's new Fibroids-focused Care Squad , which focuses on guiding participants toward a better understanding of fibroids as a health relevant condition and the possible linkage between fibroids and other health diagnoses.
  • With a wealth of experience in fibroids, endometriosis, and disparities in maternal morbidity and mortality, Dr. Noel is a leading voice in women's health and developed the content for the Fibroids-focused Care Squad.

Cormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream Infections

Retrieved on: 
Thursday, June 15, 2023
Face, Infection, Boston Medical Center, Health equity, CVC, Fungal infection, Catheter, Dialysis, Incidence, Patient, Patient safety, Risk, Mortality, Health, Bloodstream infections, Medical device, Pharmaceutical industry

CorMedix and Boston Medical Center will assess the incidence and scope of CRBSIs, care inequities in patients experiencing CRBSIs, total potential costs of treatment, and CRBSI-related readmissions.

Key Points: 
  • CorMedix and Boston Medical Center will assess the incidence and scope of CRBSIs, care inequities in patients experiencing CRBSIs, total potential costs of treatment, and CRBSI-related readmissions.
  • This assessment will form the baseline from which CorMedix and Boston Medical Center will evaluate the impact that infection prevention can have on reducing the health disparities that structurally marginalized patient populations often face.
  • Boston Medical Center, the largest essential hospital in New England, provides world-class care to all, with an emphasis on clinical excellence and health equity.
  • With one million patient visits annually and unique community partnerships designed to empower patients and help communities thrive, Boston Medical Center is committed to improving the health of communities.

Work Health Solutions Names Dr. Peter Lee Chief Executive Officer

Retrieved on: 
Wednesday, June 14, 2023
Managed Care, Health, Telemedicine, Virtual Medicine, Other Health, University, General Electric, Intuition, American College of Occupational and Environmental Medicine, Boston Medical Center, Chapel Hill, Employment, Global health, Multimedia, Preventive healthcare, University of North Carolina at Pembroke, Africa/Harvard School of Public Health Partnership for Cohort Research and Training, Occupational Safety and Health Act 1994, Public health, Medical director, MD, Robert Larner College of Medicine, Global Medical Aid, American College, Harvard School of Dental Medicine, Environmental medicine, Management, Amazon

Work Health Solutions, providers of concierge-style occupational medicine for large-scale employers nationwide, announces the appointment of Peter Lee, MD as Chief Executive Officer.

Key Points: 
  • Work Health Solutions, providers of concierge-style occupational medicine for large-scale employers nationwide, announces the appointment of Peter Lee, MD as Chief Executive Officer.
  • Most recently, Dr. Lee served as Global Medical Director for Amazon where he led clinical operations and industrial hygiene, directed occupational health and wellness, developed worldwide responsive health policies, and drove advancements in health technology, global health security and benefits design.
  • View the full release here: https://www.businesswire.com/news/home/20230614816100/en/
    Peter Lee, MD - Amazon’s Former Global Medical Director, now Chief Executive Officer of Work Health Solutions, providers of concierge-style occupational medicine for large-scale employers nationwide.
  • (Photo: Business Wire)
    “At Amazon, we enlisted Work Health Solutions as a strategic partner, and they exceeded every expectation with their unique approach and exceptional customer service.

TUFTS MEDICINE JOINS BLUE CROSS BLUE SHIELD OF MASSACHUSETTS' VALUE-BASED PAYMENT CONTRACT INCORPORATING EQUITY MEASURES

Retrieved on: 
Tuesday, May 23, 2023
Partnership, Health care, Blue Cross Blue Shield Association, Blue Cross, Boston Medical Center, Health equity, Private practice, Hypertension, Community Healthcare Network, Hospital, Patient, Physician, Colorectal cancer, Child, Patient safety organization, Adolescence, Mass General Brigham, Health, Health insurance, Pharmaceutical industry, Nursing

BOSTON, May 23, 2023 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") today announced that Tufts Medicine is now part of the health plan's pay-for-equity financial payment model. Blue Cross is the first health plan in Massachusetts — and among the first in the nation — to introduce these contracts, which link financial incentives to achieving measurable improvements in health equity.

Key Points: 
  • BOSTON, May 23, 2023 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") today announced that Tufts Medicine is now part of the health plan's pay-for-equity financial payment model .
  • With the addition of Tufts Medicine, 53% of Blue Cross' Massachusetts members now receive care from clinicians taking part in these equity-focused value-based agreements.
  • As part of its agreement with Blue Cross, Tufts Medicine will focus on reducing inequities in colorectal cancer screenings, diabetes care, hypertension, and child and adolescent well-care visits.
  • "Like Blue Cross, Tufts Medicine is committed to improving equity and eliminating racial and ethnic inequities in care," said Dr. Mark Friedberg, senior vice president, performance measurement & improvement at Blue Cross.

The Institute for Functional Medicine Announces In-Person 2023 Annual International Conference: Advancements in Clinical Research and Innovative Practices in Functional Medicine

Retrieved on: 
Tuesday, May 2, 2023
Well, White House, Human, Medicine, Mark Hyman (doctor), Mayo Clinic, Alternative medicine, Multidisciplinary Association for Psychedelic Studies, The New York Times, Face, Genomics, Boston Medical Center, Personalized medicine, Research, CDC, Pioneer, American Board of Commissioners for Foreign Missions, Annual International Conference on Real Options, MAPS, Patient, MSES, Internal medicine, AIC, German Resource Center for Genome Research, Functional medicine, Health, III, Conference, PTSD, Conditional sentence, Disease, Medical device, Nursing, Hospital, Management, Genetics

FEDERAL WAY, Wash., May 02, 2023 (GLOBE NEWSWIRE) -- The Institute for Functional Medicine (IFM) is excited to announce its 2023 Annual International Conference (AIC): Advancements in Clinical Research and Innovative Practices in Functional Medicine , which will be held June 1-3, 2023 at Rosen Shingle Creek in Orlando, FL.

Key Points: 
  • FEDERAL WAY, Wash., May 02, 2023 (GLOBE NEWSWIRE) -- The Institute for Functional Medicine (IFM) is excited to announce its 2023 Annual International Conference (AIC): Advancements in Clinical Research and Innovative Practices in Functional Medicine , which will be held June 1-3, 2023 at Rosen Shingle Creek in Orlando, FL.
  • This year’s conference will feature keynote speakers, plenary sessions, and networking opportunities to explore a wide range of topics related to functional medicine.
  • Executive Director of Duke Health and Well-Being and former director for Group Visits and Wellness-Based Healthcare Transformation at Boston Medical Center.
  • Stanford W. Ascherman Professor and Chair of Genetics and the director of the Center for Genomics and Personalized Medicine.